A Study of a Side Effects and Resource Navigation Program for People With Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program impacts participants' quality of life. Investigators will measure quality of life by having participants complete questionnaires.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Documentation of Disease
Prior Treatment
Age ≥ 18 (per EMR)
Not Pregnant and Not Nursing (per self-report)
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Immunotherapy CARE Program
Other interventionFor participants assigned to the I CARE arm, CCNY staff will assist in monthly essential needs and side effects/symptom reporting navigation
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: I CARE GroupExperimental treatment 1 intervention
Group B: U&C GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Immune Checkpoint Inhibitors/ICI continuation
Participant ICI appointment and treatment adherence will be documented through chart abstraction (research staff EMR review) at 6 months
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov